Since 2005 · Boston, MA · USA & Japan
Strategic consulting for precision oncology and clinical diagnostics companies, investors, and emerging technologies seeking market advantage.
Clinical diagnostics companies seeking market advantage and growth
New technologies and products navigating the path to commercialization
Investors and financial institutions evaluating diagnostics opportunities
What We Do
Road maps from discovery to market. Product design, business and marketing plans for diagnostics assets.
Business and technical assessment for investors. Rigorous evaluation of diagnostics assets and companies.
Deal structuring, strategic alliances, and board advisory to accelerate business development.
Custom market and competitor analysis to inform strategy and uncover opportunity.
Regulatory strategy, PMDA navigation, and commercial partnership development for the Japanese IVD market.
Implementation support, CEO/COO/VP BD capacity for companies requiring senior leadership bandwidth.
Identification of investment and partnership opportunities in diagnostics and precision medicine.
Functional planning across disciplines: technical, clinical, regulatory, commercial, and financial.
How We Work
Senior Consultants
SCP founder since 2005. Executive roles at Pillar Biosciences, Prolias (CEO), Stem Cell Preservation Technologies (President/COO), IQuum/Roche (VP BD), Large Scale Biology, and Dade Behring/Siemens.
Early career fellowships from Max-Planck-Society and Harvard University at MGH, Harvard Medical School, and Center for Blood Research. Published in oncology, infectious diseases, and in vivo imaging.
30+ years in IVD, life sciences, and analytical instrumentation. Representative Director & GM at Exact Sciences KK (Japan), leading Oncotype DX Breast RS commercialization in precision oncology.
Senior roles at Hitachi High-Tech including U.S. subsidiary President, driving global sales, M&A, and launches in clinical chemistry, microbiology, molecular diagnostics, DNA sequencing, and immunoassays. 10+ years international experience (Germany, U.S.).
Hands-on molecular diagnostics development for infectious diseases at IntelligentMDx, progressing through Senior Scientist, Product Development Manager, and Marketing Manager roles encompassing market analysis, competitive intelligence, and technical writing.
Senior Science Analyst at Bioinformatics LLC; prior microbiology research at Nestlé R&D. Published in HIV and immunology.
Track Record
Pillar Biosciences — Head of BD & CCO. Deals with Illumina, MGI, Columbia University, LabCorp, Thrive, PierianDx, Beckman Coulter, Hitachi High-Tech. Sales partnerships across US, ASEAN, South Korea, Israel, and Japan.
Prolias — CEO. License deals with Bio-Rad and Invitrogen/Life Technologies; led company to successful exit.
Views & News
Japan's IVD market offers significant opportunity for precision oncology diagnostics — but the path through PMDA requires a fundamentally different strategy than FDA or CE-mark submissions. Companies that treat PMDA as a translation exercise rather than a distinct regulatory engagement consistently underestimate timeline and cost.
Scholz Consulting Partners is pleased to announce the addition of Kazuhiro Matsumura as Country Manager, Japan. With 30+ years of IVD and life science experience — including leadership at Exact Sciences KK and Hitachi High-Tech — Mats strengthens SCP's ability to support clients navigating the Japanese diagnostics market.
Get In Touch
Whether you are evaluating a diagnostics asset, entering a new market, or need experienced leadership capacity, we are here to help.